Apple Inc. is tackling an import ban issue – a ban that has resulted in their most significant money-making Apple Watch models removed from the store shelves over the holiday season. The suspension, due to a patent-infringement loss to medical-device creator Masimo Corp., has driven the Cupertino-based leading tech company to resort to unconventional strategies to circumvent the hindrance. The key player in this trademark dispute, Apple Watch Series 9 and Ultra 2 have been able to reappear on the market, thanks to a temporary reprieve granted by a federal appeals court on Wednesday. This verdict came one day after the sales of the device in the U.S. were put to a stop.
Apple’s strategy against its recent ban reveals an interesting trend within the legal landscape of corporate battles. Firms like Apple are increasingly favoring multi-angular approaches to resolve import blockades – a maneuver that possibly stands as a lesson for other companies facing a similar predicament. Apple’s approach, temporary relief aside, signals an adherence to its commitment to its product and its consumers and showcases how innovation continues to be a rung on the ladder leading to legal triumphs.
To read about the issue in its entirety, visit the full report.